PortViewPortView
BiondVax Pharmaceuticals logo

BiondVax Pharmaceuticals (BVXV) Stock Analysis

NASDAQHealthcareBiotechnology

$1.36+0.74%
1-year price historyRange $0.80 – $10.96
52-week range$1.36
$0.63$11.49

What BiondVax Pharmaceuticals does

BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.

Key metrics

Market cap
$4.97M
P/E (TTM)
-0.58
EPS (TTM)
$-2.35
Beta
2.37
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$1.17
200-day avg
$1.79
52-week high
$11.49
52-week low
$0.63
CEO
Amir Reichman

ETFs linked to BVXV

Broad-market and Healthcare sector ETFs an investor holding BiondVax Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BVXV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BVXV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals trades under the ticker BVXV on NASDAQ.
Which exchange is BVXV listed on?
BVXV is listed on NASDAQ.
What sector does BiondVax Pharmaceuticals operate in?
BiondVax Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BVXV in a portfolio?
PortView shows BVXV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.